Trade Shows

Trade Resources Search Results

Type

Location

Industry

View More

2 results for "

Pain Drug

"

Purdue Pharma Has Obtained Approval From The US Food and Drug Administration
Sep 27, 2013
Purdue Pharma has obtained approval from the US Food and Drug Administration (FDA) for the launch of a new 15mcg/hr dosage strength of Butrans (buprenorphine) Transdermal System CIII. Following the approval, Butrans will be available in ...

Tags: Pain Drug, Purdue Pharma
FDA Has Scheduled a Meeting on 03 October 2013 to Discuss QRxPharma's Moxduo NDA
Sep 10, 2013
The US Food and Drug Administration (FDA) has scheduled a meeting on 03 October 2013 to discuss QRxPharma's Moxduo new drug application (NDA) for the treatment of moderate to severe acute pain. The meeting is aimed at focusing on ...

Tags: Acute Pain Drug

Related Products